These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15437793)

  • 41. [Studies on incomplete antibodies in the course of imunization for typhoid fever. 2. On incomplete antibodies in a patient receiving typhoid-paratyphoid vaccine].
    MIZUTANI T
    Nihon Saikingaku Zasshi; 1961 Jun; 16():439-42. PubMed ID: 13771548
    [No Abstract]   [Full Text] [Related]  

  • 42. [Characterization of typhoid O and H agglutinins and paratyphoid A and B agglutinins in full-term newborn infants after stimulation with typhoid-paratyphoid vaccine].
    Turbessi G; Ungari S; Aiuti F; Serra GB; Ricci G
    Riv Ist Sieroter Ital; 1966; 41(4):255-63. PubMed ID: 4966014
    [No Abstract]   [Full Text] [Related]  

  • 43. [Is there the danger of a Sanarelli-Shwartzman reaction in the use of pyrifer?].
    GEKS FJ; HAGEMANN R
    Munch Med Wochenschr; 1950 May; 92(7-8):288-9. PubMed ID: 15438976
    [No Abstract]   [Full Text] [Related]  

  • 44. [Evaluation of immunizing properties of precipitated typhoid-paratyphoid vaccine in white mice].
    MAZUR W
    Med Dosw Mikrobiol; 1951; 3(2):185-97. PubMed ID: 14874890
    [No Abstract]   [Full Text] [Related]  

  • 45. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of typhoid and paratyphoid fever with chloromycetin and artificial fever].
    HORING FO
    Ther Ggw; 1951 May; 90(5):161-6. PubMed ID: 14835540
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness of typhoid and paratyphoid absorbed vaccines].
    HAAS R
    Z Hyg Infektionskr; 1953 Jan; 136(3):245-51. PubMed ID: 13090989
    [No Abstract]   [Full Text] [Related]  

  • 48. [Mixed paratyphoid B and typhoid infection; on chloromycetin therapy of typhoid diseases].
    KNAPP W; GERMER WD
    Z Hyg Infektionskr; 1951; 132(1):23-8. PubMed ID: 14818279
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of typhoid with chloromycetin and the association of T.A.B. vaccine therapy].
    DEBRAY M; PROVENDIER M; WATTEBLED R
    Therapie; 1950; 5(5):250-4. PubMed ID: 14787989
    [No Abstract]   [Full Text] [Related]  

  • 50. Typhoid vaccine intramuscularly as office therapy.
    ROSNER RS
    Eye Ear Nose Throat Mon; 1955 Aug; 34(8):507. PubMed ID: 13241527
    [No Abstract]   [Full Text] [Related]  

  • 51. Typhoid vaccine studies; the effect and effectiveness of three 0.5-ml doses of TAB vaccine.
    LUIPPOLD GF; LONGFELLOW D; TOPOREK M
    Am J Hyg; 1947 May; 45(3):355-62. PubMed ID: 20240020
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of typhoid and paratyphoid fever].
    DENNIG H
    Dtsch Med J; 1953 May; 4(9-10-11-12):248-50. PubMed ID: 13083359
    [No Abstract]   [Full Text] [Related]  

  • 53. Response of normal and multiple sclerotic subjects to typhoid-paratyphoid vaccine injections.
    FIELD EJ; GREEN CA; MILLER H
    J Neurol Neurosurg Psychiatry; 1961 Feb; 24(1):78-9. PubMed ID: 13699347
    [No Abstract]   [Full Text] [Related]  

  • 54. A laboratory comparison of United States and British army typhoid-paratyphoid vaccine.
    MILLER WS; CLARK DL; DIERKHISING OC
    Am J Trop Med Hyg; 1951 Sep; 31(5):535-51. PubMed ID: 14878097
    [No Abstract]   [Full Text] [Related]  

  • 55. [Typhoid-paratyphoid endotoxin in prevention of typhoid infections. Application and results of 15 years of vaccination (1934-1948)].
    GRASSET E
    Rev Immunol Ther Antimicrob; 1951; 15(1-2):1-19. PubMed ID: 14865368
    [No Abstract]   [Full Text] [Related]  

  • 56. [On the problem of experimental evaluation of vaccines against typhoid and paratyphoid].
    MATEJOVSKA D; JELINEK J; RASKA K
    Cesk Epidemiol Mikrobiol Imunol; 1959 Sep; 8():299-303. PubMed ID: 14422227
    [No Abstract]   [Full Text] [Related]  

  • 57. [Advances in the preparation of combined vaccine against abdominal typhus, paratyphoid and tetanus (TABTe vaccine)].
    LA ROCCA V; BENZONI G
    Boll Ist Sieroter Milan; 1961; 40():18-29. PubMed ID: 13757935
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of typhoid-paratyphoid A and B vaccine on the antigenic efficiency of tetanus toxoids of different quality.
    BARR M
    Br J Exp Pathol; 1956 Feb; 37(1):11-9. PubMed ID: 13304236
    [No Abstract]   [Full Text] [Related]  

  • 59. [Production of mucus in the typhoid-paratyphoid-coli group as a mutation phenomenon].
    RAETTIG H
    Zentralbl Bakteriol Orig; 1951 Aug; 157(1-2):62-5. PubMed ID: 14884664
    [No Abstract]   [Full Text] [Related]  

  • 60. Relapses in fevers of typhoid paratyphoid groups.
    DE FIGUEIREDO JM
    Antiseptic; 1952 Apr; 49(4):285-7. PubMed ID: 14924553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.